DARPP-32 integrates the activities of dopaminergic and glutamatergic transmission in the striatum (Svenningsson et al., 2004; Fernandez et al., 2006), and is, therefore, thought to be a key regulator for the emergence of PD symptoms (Greengard, 2001). This evidence concerns the gene PPP1R1B and Parkinson disease.